Recently published research suggests U.S. spending on cancer, which outpaces other countries, may lead to greater survival gains among patients, according to an NPR report.
Researchers from the University of Chicago and the University of Southern California sought to determine how much the U.S. and 10 European countries spent on cancer care and what outcomes were associated with those healthcare costs. Their analysis showed that while U.S. spending increased dramatically (49 percent) faster than Europe (16 percent) from 1983 to 1999, U.S. patient also saw longer average survival times (11.1 years) than Europe (9.3 years).
The authors did note the study may be limited due to reliance on older data. They suggest further research may help better understand the value of increased healthcare spending on cancer care.
Researchers from the University of Chicago and the University of Southern California sought to determine how much the U.S. and 10 European countries spent on cancer care and what outcomes were associated with those healthcare costs. Their analysis showed that while U.S. spending increased dramatically (49 percent) faster than Europe (16 percent) from 1983 to 1999, U.S. patient also saw longer average survival times (11.1 years) than Europe (9.3 years).
The authors did note the study may be limited due to reliance on older data. They suggest further research may help better understand the value of increased healthcare spending on cancer care.
Related Articles on Cancer Care:
Patients Test Negative for Blood Infections From Poor Quality at Shuttered Cancer Center
Long Island Jewish Medical Center in New York Opens New Cardiovascular Unit
Price Tags of Preventive Services Costs Could Vary Up to 755%